GÜVEN, D. C. Et Al. 2022. The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.174 .

GÜVEN, D. C., Stephen, B., ŞAHİN, T. K., ÇAKIR, İ. Y., Erul, E., & AKSOY, S., (2022). The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.174.

GÜVEN, DENİZ Et Al. "The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials," CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.174, 2022

GÜVEN, DENİZ C. Et Al. "The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.174, 2022

GÜVEN, D. C. Et Al. (2022) . "The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.174.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials}, journal={CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY}, year=2022}